Cargando…

Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

BACKGROUND: The interaction between tumor microenvironment (TME) and tumors offers various targets in mounting anti-tumor immunotherapies. However, the prognostic biomarkers in endometrial carcinoma (EC) are still limited. Here, we aimed to analyze the TME features and identify novel prognostic biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Heng, Feng, Peng-hui, Yu, Shuang-ni, Lu, Zhao-hui, Yu, Qi, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107201/ https://www.ncbi.nlm.nih.gov/pubmed/35562682 http://dx.doi.org/10.1186/s12885-022-09654-6

Ejemplares similares

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
por: Ma, Heng, et al.
Publicado: (2022)

Association of TNFRSF12A Methylation With Prognosis in Hepatocellular Carcinoma With History of Alcohol Consumption
por: Wang, Yi, et al.
Publicado: (2020)

TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer
por: Zhou, Cong, et al.
Publicado: (2018)

Bioinformatics Analysis Identifies TNFRSF1A as a Biomarker of Liver Injury in Sepsis TNFRSF1A is a Biomarker for Septic Liver Injury
por: Zhou, Shangxun, et al.
Publicado: (2022)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation
por: You, Shuang, et al.
Publicado: (2023)

Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2020)

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
por: Wu, Zhicheng, et al.
Publicado: (2022)

Association of Genetic Polymorphisms in TNFRSF11 with the Progression of Genetic Susceptibility to Gastric Cancer
por: Fan, Yu, et al.
Publicado: (2020)

Association of TNF-α, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women
por: Xu, Fengyan, et al.
Publicado: (2014)

Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
por: Li, Yaohui, et al.
Publicado: (2020)

Identification of a 5-gene-based signature to predict prognosis and correlate immunomodulators for rectal cancer
por: Yi, Lin, et al.
Publicado: (2022)

TNFα Causes a Shift in Gene Expression of TNFRSF1A and TNFRSF1B Isoforms
por: Perik-Zavodskaia, Olga, et al.
Publicado: (2023)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Alterations in bone fracture healing associated with TNFRSF signaling pathways
por: Dong, Yanzhao, et al.
Publicado: (2022)

Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients
por: Chen, Shan, et al.
Publicado: (2021)

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
por: Liu, JinHui, et al.
Publicado: (2020)

Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma
por: Lan, Hua, et al.
Publicado: (2021)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
por: Ye, Youchun, et al.
Publicado: (2021)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
por: Cheng, Li, et al.
Publicado: (2019)

TNFRSF12A and a new prognostic model identified from methylation combined with expression profiles to predict overall survival in hepatocellular carcinoma
por: Fang, Yu, et al.
Publicado: (2020)

Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma
por: Wang, Na, et al.
Publicado: (2021)

TNFRSF13B is a potential contributor to prostate cancer
por: Li, Chia-Yang, et al.
Publicado: (2022)

On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function
por: Vanamee, Éva S., et al.
Publicado: (2020)

The role of TNFRSF11B in development of osteoarthritic cartilage
por: Rodríguez Ruiz, Alejandro, et al.
Publicado: (2021)

Editorial: TNFRSF agonists: mode of action and therapeutic opportunities
por: Obermajer, Nataša, et al.
Publicado: (2023)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data
por: Huo, Xiao, et al.
Publicado: (2019)

Identification of inflammatory-related gene signatures to predict prognosis of endometrial carcinoma
por: Chen, Linlin, et al.
Publicado: (2022)

Identification and validation of immune and prognosis-related genes in hepatocellular carcinoma: A review
por: Chen, Yu-Yang, et al.
Publicado: (2022)

Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid
por: Yang, Jianing, et al.
Publicado: (2023)

Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer
por: Lu, Jing, et al.
Publicado: (2021)

Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis
por: Xing-rong, Wang, et al.
Publicado: (2018)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

TNFRSF13B in B cell responses to organ transplantation
por: Cascalho, Marilia, et al.
Publicado: (2023)

TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis
por: Zhang, Jun-rong, et al.
Publicado: (2021)

Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
por: Yuan, Yi, et al.
Publicado: (2021)

Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer
por: Gao, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pbcti3ms222iajggisaptl8jn4